about
sameAs
Polymeric nanoparticles for targeted radiosensitization of prostate cancer cellsDOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.Effect of PF-02341066 and radiation on non-small cell lung cancer cells.Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy.Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer
P50
Q35040431-4B54770B-FA95-47E0-B7C8-4DEFBCC6141CQ35729485-9843F9BD-B041-497F-84A5-1D444C8BC744Q37694026-7B0C8010-B74F-4ECD-A95B-95557BFC5EF9Q38676437-2CCF16F9-35C6-4FCE-805F-7A118BCD57E2Q38990477-FB46829E-1B41-4373-8E31-5E52A3425D00Q39872066-F4C22544-F2B4-4CC1-974F-6D7E2F0CBF09Q90481634-52183D4E-ED6E-4293-B020-CD7543F4898A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3908-6166
@en
name
Vasu Tumati
@ast
Vasu Tumati
@en
Vasu Tumati
@es
Vasu Tumati
@nl
type
label
Vasu Tumati
@ast
Vasu Tumati
@en
Vasu Tumati
@es
Vasu Tumati
@nl
prefLabel
Vasu Tumati
@ast
Vasu Tumati
@en
Vasu Tumati
@es
Vasu Tumati
@nl
P106
P1153
55308013600
P31
P496
0000-0003-3908-6166